CN113456668A - 一种女性外用软膏及其制备方法 - Google Patents
一种女性外用软膏及其制备方法 Download PDFInfo
- Publication number
- CN113456668A CN113456668A CN202110585026.7A CN202110585026A CN113456668A CN 113456668 A CN113456668 A CN 113456668A CN 202110585026 A CN202110585026 A CN 202110585026A CN 113456668 A CN113456668 A CN 113456668A
- Authority
- CN
- China
- Prior art keywords
- parts
- tablets
- portions
- ointment
- nystatin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 16
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 claims abstract description 13
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229960003088 loratadine Drugs 0.000 claims abstract description 13
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229960000282 metronidazole Drugs 0.000 claims abstract description 13
- 229960000988 nystatin Drugs 0.000 claims abstract description 13
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 claims abstract description 13
- 229960003291 chlorphenamine Drugs 0.000 claims abstract description 10
- WJOHZNCJWYWUJD-IUGZLZTKSA-N Fluocinonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)C)[C@@]2(C)C[C@@H]1O WJOHZNCJWYWUJD-IUGZLZTKSA-N 0.000 claims abstract description 8
- 229960000785 fluocinonide Drugs 0.000 claims abstract description 8
- MLKXDPUZXIRXEP-MFOYZWKCSA-N sulindac Chemical compound CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(S(C)=O)C=C1 MLKXDPUZXIRXEP-MFOYZWKCSA-N 0.000 claims abstract description 4
- 229960000894 sulindac Drugs 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 3
- FKENQMMABCRJMK-RITPCOANSA-N sulbactam Chemical compound O=S1(=O)C(C)(C)[C@H](C(O)=O)N2C(=O)C[C@H]21 FKENQMMABCRJMK-RITPCOANSA-N 0.000 claims description 2
- 229960005256 sulbactam Drugs 0.000 claims description 2
- 229940100615 topical ointment Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 2
- 201000004624 Dermatitis Diseases 0.000 description 10
- 230000000694 effects Effects 0.000 description 7
- 208000003251 Pruritus Diseases 0.000 description 5
- 201000009053 Neurodermatitis Diseases 0.000 description 4
- 208000024780 Urticaria Diseases 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 206010046914 Vaginal infection Diseases 0.000 description 3
- 201000008100 Vaginitis Diseases 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 2
- 208000008818 Chronic Mucocutaneous Candidiasis Diseases 0.000 description 2
- 206010028080 Mucocutaneous candidiasis Diseases 0.000 description 2
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 2
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000003756 cervix mucus Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 208000004145 Endometritis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- 241000224526 Trichomonas Species 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 208000002003 vulvitis Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种女性外用软膏，包括甲硝唑片8‑12份、制霉菌素片8‑12份、氯雷他定片8‑12份、扑尔敏8‑12份、冰硼散13‑17份和肤轻松乳膏103‑107份。本发明属于医药技术领域，具体是一种女性外用软膏及其制备方法，取之于专门治疗妇科疾病药物之精华，归结一处药效，一药多效，价格适当使用方便，直达病处，疗效快。
Description
技术领域
本发明属于医药技术领域，具体是指一种女性外用软膏及其制备方法。
背景技术
女性外阴炎、阴道炎、宫颈糜烂、子宫内膜炎、附件炎；霉菌、滴虫所致瘙痒、渗出、出血、疼痛等症是临床妇科炎症的多见症状，常见的方法是通过中医采取清热解毒、利湿化浊、凉血止血的手段对其进行治疗。但实践中，由于许多中药具有起效慢、疗程长、使用不方便等缺点，严重影响其临床应用。
发明内容
针对上述情况，为克服现有技术的缺陷，本发明提供一种女性外用软膏及其制备方法，取之于专门治疗妇科疾病药物之精华，归结一处药效，一药多效，价格适当使用方便，直达病处，疗效快；可进行杀菌、杀虫、霉菌性阴道炎、细菌性阴道炎、荨麻疹、湿疹、皮炎、神经性皮炎、皮肤瘙痒的治疗；缓解由细菌引起阴道炎疾病；滴虫性阴道炎所致的阴道分泌物异常、异味，慢性粘膜皮肤念珠菌病；皮肤过敏症、荨麻疹、湿疹、皮炎、皮肤瘙痒、神经性皮炎；缓解疼痛、清热解毒、消肿止痛、溃疡糜烂。
本发明采取的技术方案如下：本发明一种女性外用软膏，包括甲硝唑片8-12份、制霉菌素片8-12份、氯雷他定片8-12份、扑尔敏8-12份、冰硼散13-17份和肤轻松乳膏103-107份。
进一步地，包括甲硝唑片9-11份、制霉菌素片9-11份、氯雷他定片9-11份、扑尔敏9-11份、冰硼散14-16份和肤轻松乳膏104-106份。
进一步地，包括甲硝唑片10份、制霉菌素片10份、氯雷他定片10份、扑尔敏10份、冰硼散15和肤轻松乳膏105份。
本发明一种女性外用软膏的制备方法，包括如下步骤：
1)将甲硝唑、制霉菌片、氯雷他定或扑尔敏碾制成粉末；
2)加入冰硼散和肤轻松乳膏一起搅拌一体，变成粘状即成药合成。
采用上述结构本发明取得的有益效果如下：本方案一种女性外用软膏及其制备方法，取之于专门治疗妇科疾病药物之精华，归结一处药效，一药多效，价格适当使用方便，直达病处，疗效快；可进行杀菌、杀虫、霉菌性阴道炎、细菌性阴道炎、荨麻疹、湿疹、皮炎、神经性皮炎、皮肤瘙痒的治疗；缓解由细菌引起阴道炎疾病；滴虫性阴道炎所致的阴道分泌物异常、异味，慢性粘膜皮肤念珠菌病；皮肤过敏症、荨麻疹、湿疹、皮炎、皮肤瘙痒、神经性皮炎；缓解疼痛、清热解毒、消肿止痛、溃疡糜烂。
具体实施方式
下面将结合本发明实施例，对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例；基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
本发明一种女性外用软膏，包括甲硝唑片8-12份、制霉菌素片8-12份、氯雷他定片8-12份、扑尔敏8-12份、冰硼散13-17份和肤轻松乳膏103-107份。
包括甲硝唑片9-11份、制霉菌素片9-11份、氯雷他定片9-11份、扑尔敏9-11份、冰硼散14-16份和肤轻松乳膏104-106份。
包括甲硝唑片10份、制霉菌素片10份、氯雷他定片10份、扑尔敏10份、冰硼散15和肤轻松乳膏105份。
本发明一种女性外用软膏的制备方法，包括如下步骤：
1)将甲硝唑、制霉菌片、氯雷他定或扑尔敏碾制成粉末；
2)加入冰硼散和肤轻松乳膏一起搅拌一体，变成粘状即成药合成。
具体使用时，用户将该药膏置于阴道中，一次使用15克，连续使用七天为一个疗程，早晚各用一次，严重者听医嘱，孕妇禁用，以上便是本发明整体的工作流程，下次使用时重复此步骤即可。
需要说明的是，在本文中，诸如第一和第二等之类的关系术语仅仅用来将一个实体或者操作与另一个实体或操作区分开来，而不一定要求或者暗示这些实体或操作之间存在任何这种实际的关系或者顺序。而且，术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含，从而使得包括一系列要素的过程、方法、物品或者设备不仅包括那些要素，而且还包括没有明确列出的其他要素，或者是还包括为这种过程、方法、物品或者设备所固有的要素。
尽管已经示出和描述了本发明的实施例，对于本领域的普通技术人员而言，可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型，本发明的范围由所附权利要求及其等同物限定。
以上对本发明及其实施方式进行了描述，这种描述没有限制性，只是本发明的实施方式之一，并不局限于此。总而言之如果本领域的普通技术人员受其启示，在不脱离本发明创造宗旨的情况下，不经创造性的设计出与该技术方案相似的结构方式及实施例，均应属于本发明的保护范围。
Claims (4)
1.一种女性外用软膏，其特征在于；包括甲硝唑片8-12份、制霉菌素片8-12份、氯雷他定片8-12份、扑尔敏8-12份、冰硼散13-17份和肤轻松乳膏103-107份。
2.根据权利要求1所述的一种女性外用软膏，其特征在于；包括甲硝唑片9-11份、制霉菌素片9-11份、氯雷他定片9-11份、扑尔敏9-11份、冰硼散14-16份和肤轻松乳膏104-106份。
3.根据权利要求2所述的一种女性外用软膏，其特征在于；包括甲硝唑片10份、制霉菌素片10份、氯雷他定片10份、扑尔敏10份、冰硼散15和肤轻松乳膏105份。
4.一种女性外用软膏的制备方法，其特征在于；包括如下步骤：
1)将甲硝唑、制霉菌片、氯雷他定或扑尔敏碾制成粉末；
2)加入冰硼散和肤轻松乳膏一起搅拌一体，变成粘状即成药合成。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110585026.7A CN113456668A (zh) | 2021-05-27 | 2021-05-27 | 一种女性外用软膏及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110585026.7A CN113456668A (zh) | 2021-05-27 | 2021-05-27 | 一种女性外用软膏及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113456668A true CN113456668A (zh) | 2021-10-01 |
Family
ID=77871564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110585026.7A Pending CN113456668A (zh) | 2021-05-27 | 2021-05-27 | 一种女性外用软膏及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113456668A (zh) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1492917A (en) * | 1975-05-17 | 1977-11-23 | Bayer Ag | Granules and powders for the preparation of ointments |
| CN1562003A (zh) * | 2004-03-16 | 2005-01-12 | 白宏臣 | 复方甲硝唑乳膏 |
| CN106619741A (zh) * | 2016-12-28 | 2017-05-10 | 河南八灵电子科技有限公司 | 一种用于治疗湿疹的药物及其制备方法 |
| CN106668864A (zh) * | 2016-10-19 | 2017-05-17 | 毕明华 | 一种治疗皮肤病的外用药膏 |
| CN108524537A (zh) * | 2018-06-27 | 2018-09-14 | 赵怀邦 | 一种炎净散软膏 |
-
2021
- 2021-05-27 CN CN202110585026.7A patent/CN113456668A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1492917A (en) * | 1975-05-17 | 1977-11-23 | Bayer Ag | Granules and powders for the preparation of ointments |
| CN1562003A (zh) * | 2004-03-16 | 2005-01-12 | 白宏臣 | 复方甲硝唑乳膏 |
| CN106668864A (zh) * | 2016-10-19 | 2017-05-17 | 毕明华 | 一种治疗皮肤病的外用药膏 |
| CN106619741A (zh) * | 2016-12-28 | 2017-05-10 | 河南八灵电子科技有限公司 | 一种用于治疗湿疹的药物及其制备方法 |
| CN108524537A (zh) * | 2018-06-27 | 2018-09-14 | 赵怀邦 | 一种炎净散软膏 |
Non-Patent Citations (4)
| Title |
|---|
| 刘新兰等: "肤轻松制霉菌素甲硝唑在妇科疾病中的协同使用", 《安庆医学》 * |
| 王昱霖: "甲硝唑片混合冰硼散配伍康妇消炎栓治疗慢性宫颈炎的临床分析", 《中国农村卫生》 * |
| 王燕 等: ""制霉菌素联合冰硼散阴道上药治疗单纯性假丝酵母菌性阴道炎的临床观察"", 《基层医学论坛》 * |
| 陈冰心: ""制霉菌素配伍冰硼散加减治疗念珠菌性阴道病"", 《浙江中西医结合杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101810642B (zh) | 一种治疗口腔溃疡和急性扁桃体炎的中药制剂及制备方法 | |
| CN101744976B (zh) | 一种杀菌止痒的洗剂及其制备方法 | |
| CN104096163A (zh) | 用于女性卵巢及内外阴养护保洁的外用药剂 | |
| CN104147108A (zh) | 含有褐藻寡糖的抑菌凝胶 | |
| CN103800510B (zh) | 一种外用洗液组方及制备方法 | |
| CN113456668A (zh) | 一种女性外用软膏及其制备方法 | |
| CN110623993A (zh) | 治疗妇科炎症的中药组合物的复合营养片及其制备方法 | |
| CN103239676A (zh) | 一种用于防治细菌性阴道病的外用药物组合物 | |
| CN103182043A (zh) | 一种治疗妇科炎症的外用中药及其制备方法 | |
| CN110302273A (zh) | 一种中药抑菌凝胶及其制备方法和应用 | |
| CN102485247B (zh) | 一种治疗妇科疾病的中药组合物及其制备方法 | |
| CN106728166A (zh) | 治疗湿疹皮炎的中药组合物 | |
| CN101919899B (zh) | 一种洁阴护理品 | |
| CN102247490A (zh) | 一种强效皮伤炎乳膏及其制作方法 | |
| CN105168503B (zh) | 一种用于防治放射性皮炎的外用中药组合物及其制备方法 | |
| CN1174770C (zh) | 治疗妇科炎症的外用药物及其制备方法 | |
| CN110664934B (zh) | 抗菌止痒的中药组合物及其制备方法和应用 | |
| CN1049145C (zh) | 妇女专用消毒液 | |
| CN103536706B (zh) | 一种治疗妊娠期念珠菌性阴道炎的中药薰洗剂 | |
| CN116898940B (zh) | 非哺乳期乳腺炎早期治疗的中药组合物及其制备方法 | |
| CN102872202B (zh) | 一种中老年妇女阴部护理油膏及其制备方法 | |
| CN115607592A (zh) | 复方虎杖湿润烧伤膏及其制备方法 | |
| Gv et al. | An integrative ayurvedic approach in management of breast abscess–A case report | |
| CN113750152A (zh) | 一种护理阴道松弛的外用配方 | |
| CN106266458B (zh) | 一种治疗银屑病及神经性皮炎疾病的中药组合物及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211001 |